Zydus Lifesciences

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue6,7296,2326,9767,7218,123
Expenses4,8084,5115,5385,6646,798
EBITDA2,2432,1251,9282,6892,036
Operating Profit2,0051,7891,4831,7831,463
Profit Before Tax1,9211,6871,3531,6601,307
Net Profit1,4871,233965.101,341952.40
Financial Ratios
Operating Profit Margin34.69%34.62%27.18%30.82%25.86%
Net Profit Margin22.68%21.26%16.26%20.77%12.21%
Earning Per Share (Diluted)14.5812.5110.3612.659.35
Dividends Per Share0.000.000.000.000.00